Kymera Therapeutics Stock Performance
as on October 30, 2026 at 2:15 pm IST
Day's Low
Day's High
$117.83$127.74
3.89%
Downside
4.19%
Upside
52 Week's Low
52 Week's High
$55.66$130.0554.60%
Downside
6.08%
Upside
Kymera Therapeutics share price movements today
- Previous Close
- $122.51
- Open
- $127.00
- Volume
- 858.7K
- Market Cap
- $10.1B
- Day's Low - High
- $117.83 - $127.74
- 52 Week Low - High
- $55.66 - $130.05
Kymera Therapeutics Historical Returns
- 1 Month Return
- + 9.67 %
- 3 Month Return
- + 14.57 %
- 1 Year Return
- + 99.54 %
- 3 Year Return
- + 992.69 %
- 5 Year Return
- + 108.22 %
Kymera Therapeutics Stock Fundamentals & Key Indicators
Check Kymera Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$10.1B
EPS (TTM)
-3.63
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-37.7
Industry PE ratio
2.45
PEG Ratio
-6.78
EBITDA
-358.6M
Revenue (TTM)
102.2M
Profit Margin
101.98%
Return On Equity TTM
-22.39%
Kymera Therapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Kymera Therapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| StrongBuy | $10.1B | 108.22% | -37.70 | 101.98% | 0.00% | |
| Neutral | $85.5B | -35.47% | -26.84 | -12.57% | 0.00% | |
| StrongBuy | $134.2B | 192.00% | 30.58 | 86.04% | 0.00% | |
| Buy | $83.7B | 27.94% | 19.42 | 84.86% | 0.45% |
Stock Returns calculator for Kymera Therapeutics Stock including INR - Dollar returns
The Kymera Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.
Investment Value
₹1,00,000
Kymera Therapeutics investment value today
Current value as on today
₹2,14,988
Returns
₹1,14,988
(+114.99%)
Returns from Kymera Therapeutics Stock
₹99,544 (+99.54%)
Dollar Impact
₹15,444 (+15.44%)
Analyst Recommendation on Kymera Therapeutics Stock
Based on 10 analysts
90.00%
Buy
10.00%
Hold
0.00%
Sell
Based on 10 analysts, 90% of analysts recommend a 'BUY' rating for Kymera Therapeutics. Average target price of $139.83
Kymera Therapeutics Share Price Target
Get share price movements and forecasts by analysts on Kymera Therapeutics.
What analysts predicted
12.32%UPSIDE
Target Price
$139.83
Current Price
$122.6
Analyzed by
10 Analysts
High
$180
Target
$139.83
Low
$112
Kymera Therapeutics target price $139.83, a slight upside of 12.32% compared to current price of $122.6. According to 10 analysts rating.
Indian Investors' Interest in Kymera Therapeutics Stock
Search interest for Kymera Therapeutics Stock has increased by 7% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:7% versus previous 30 day period
Kymera Therapeutics Quarterly Profit & Loss
All numbers in Millions USD
Kymera Therapeutics Annual Profit & Loss
All numbers in Millions USD
Kymera Therapeutics Quarterly Cash Flow
All numbers in Millions USD
Kymera Therapeutics Annual Cash Flow
All numbers in Millions USD
Kymera Therapeutics News & Key Events
Today's Timeline - 27 July
Tue, 01:31 AM
-Kymera Therapeutics appoints Terence Rooney as Chief Medical Officer, succeeding Jared Gollob after eight years.
Insights on Kymera Therapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTBest in 3 Years
In the last 3 years, KYMR has outperformed top 5 stocks with highest market-cap in its industry
- POSITIVE IMPACT
Price Rise
In the last 7 days, KYMR stock has moved up by 10.7%
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 4 quarters, 2.76M → 64.99M (in $), with an average increase of 47.4% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -87.02M → -61.21M (in $), with an average increase of 19.4% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 691.6% return, outperforming this stock by 592.1%
About Kymera Therapeutics
| Organisation | Kymera Therapeutics |
| Headquarters | 500 North Beacon Street, Watertown, MA, 02472, US |
| Industry | Biotechnology |
| CEO | Nello Mainolfi |
Key Management of Kymera Therapeutics
Name | Title |
|---|---|
Dr. Jeremy G. Chadwick Ph.D. | Advisor |
Dr. Nello Mainolfi M.D., Ph.D. | Co-Founder, President, CEO & Director |
Mr. Bruce N. Jacobs CFA | Chief Financial Officer |
Dr. Jared A. Gollob M.D. | Advisor |
Ms. Justine E. Koenigsberg | Vice President of Investor Relations |
Dr. Juliet Williams B.A Ph.D. | Head of Research |
Mr. Brian R. Adams J.D. | Chief Legal Officer & Corporate Secretary |
Mr. Noah Goodman M.B.A. | Chief Business Officer |
Dr. Neil Graham M.D., M.P.H., MBBS | Chief Development Officer |
Mr. Brian Albarran M.B.A., Ph.D. | SVP of Corporate Strategy |
FAQs
What is Kymera Therapeutics share price today?
Kymera Therapeutics share price today is $122.60 as on at the close of the market. Kymera Therapeutics share today touched a day high of $127.74 and a low of $117.83.
What is the 52 week high and 52 week low for Kymera Therapeutics share?
Kymera Therapeutics share touched a 52 week high of $130.05 on and a 52 week low of $55.66 on . Kymera Therapeutics stock price today i.e. is closed at $122.60,which is 5.73% down from its 52 week high and 120.27% up from its 52 week low.
What is Kymera Therapeutics's market capitalisation today?
Kymera Therapeutics market capitalisation is $0.01T as on .
How to invest in Kymera Therapeutics Stock (KYMR) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Kymera Therapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Kymera Therapeutics Stock (KYMR) from India?
Indian investors can start investing in Kymera Therapeutics (KYMR) shares with as little as ₹95.25 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.50 in Kymera Therapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Kymera Therapeutics share’s latest price of $122.60 as on October 30, 2026 at 8:45 am IST, you will get 0.0816 shares of Kymera Therapeutics. Learn more about
fractional shares .
What are the returns that Kymera Therapeutics has given to Indian investors in the last 5 years?
Kymera Therapeutics stock has given 108.22% share price returns and 27.03% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?